工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
我们的方法将酶/前药治疗和免疫治疗整合到一个单一的细菌递送系统中,通过提供合理设计的空间控制化学免疫治疗框架,克服了传统疗法的关键局限性。
英文原题:Tuning the sensitivity of mechanosensory receptors through histidine scanning.
T 细胞受体(TCR)-T 细胞疗法对实体瘤有效,但为肿瘤抗原鉴定强效、特异的 TCR 具有挑战性。
T细胞受体(TCR)T细胞疗法对实体瘤有效,但为肿瘤抗原鉴定强效且特异的TCR颇具挑战。传统亲和力成熟可能造成致命的脱靶毒性。Catch bond(捕获键)在包括TCR在内的机械感受受体信号传导中发挥关键作用,但其形成机制及缓解TCR-T疗法挑战的潜力尚不清楚。本研究显示,组氨酸扫描可识别能够形成额外捕获键的TCR热点位点,并可将其随机化以构建TCR文库,从而筛选低亲和力、高效力变体。从机制上看,组氨酸促进氢键和盐桥形成,并增强细胞内信号级联。利用该方法,我们针对不同抗原工程化构建了多种TCR,未观察到脱靶或靶向相关毒性。研究结果提出了一种通用方法,可在无需依据结构设计TCR文库的情况下,工程化获得用于安全TCR-T细胞疗法的低亲和力、高效力TCR。此外,组氨酸扫描还可广泛应用于其他机械感受型配体—受体系统。
T cell receptor (TCR)-T cell therapy is effective for solid tumors, yet identifying potent, specific TCRs for tumor antigens is challenging. Conventional affinity maturation may cause fatal off-target toxicity. Catch bonds play a crucial role in mechanosensory receptor signaling, including the TCR, but their formation and potential to mitigate the challenges of TCR-T remain unclear. Here, we demonstrate that histidine scanning can identify TCR hotspots capable of forming additional catch bonds, which can be randomized to create TCR libraries for screening low-affinity, higher-potency variants. Mechanistically, histidine facilitates the formation of hydrogen bonds and salt bridges and fortifies the intracellular signaling cascade. Using this approach, we engineered different TCRs specific for various antigens, without off-target toxicity or on-target toxicity. Our findings introduce a universal method of engineering low-affinity, high-potency TCRs for safe TCR-T cell therapy, without requiring the structure for designing TCR libraries. Additionally, histidine scanning can be broadly applied to other mechanosensory ligand-receptor systems.
MEMBER ACCOUNT
登录成功会直接打开下一页。